A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...
Miriam Merad, Mount Sinai, USA, has studied how cells in the immune system affect the body’s ability to fight tumours. Her ...
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...
Nana Kwame Wiredu Amoako is currently fighting for his life against Acute Myeloid Leukaemia (AML), a severe form of cancer.
2d
News Medical on MSNNew immune map uncovers key pancreatic cancer insightsResearchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, a ...
15h
GlobalData on MSNTC BioPharm completes dosing in Cohort A of Phase IIb trial for AMLThe trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.
February 14, 2025 – IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...
IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...
Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results